biomarker-trends-header.png

What we’ve learned about effective biomarker knowledge management

This is the first of a 5 installment series covering what we've learned about effective biomarker knowledge management over the last few years. The topic will be driven by a "maturity model" that we've developed while working with our pharmaceutical, diagnostic and consulting clients. The model ...

Chart of the Week: Pharma Trials Using Selection Biomarkers

In BiomarkerBase we track biomarker use in trials, including those biomarkers used as patient selection criteria in particular clinical trials. We used this capability in a report we recently co-authored with BIO and Informa on clinical trials success rates (spoiler: patient selection biomarkers ...

Chart of the Week: 3x Improvement in Likelihood of Approval

In May we released a report co-authored with BIO and BioMedTracker. One of the key take-aways from the report is that patient selection biomarkers, if used successfully, can triple the Likelihood of Approval (LOA) for clinical studies.  Here is the data:

Chart of the Week: Liquid Biopsy Focused on Lung Cancer

Last week we did a follow-up webinar on liquid biopsy.  In the extended analysis it became apparent that lung cancer is the focus of liquid biopsy. While breast cancer shows up on the top of this list, the combination of NSCLC and lung cancer surpasses breast cancer by 11 biomarkers in use for ...

Chart of the Week: Cost of Biomarker Information

It is more costly to get biomarker information from public sources than you think. The volume of information requires technology assistance to be efficient. AI approaches like Natural Language Processing (NLP) are the best bet for efficient gathering of clinical information.

   

August Webinar: 

Liquid Biopsy Biomarkers in Precision Medicine

RECORDING
New Call-to-action
FREE REPORT

Subscribe for Updates

Download our Free IVD Trends Report